Back to top

Image: Bigstock

RXO (RXO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

For the quarter ended March 2025, RXO (RXO - Free Report) reported revenue of $1.43 billion, up 57% over the same period last year. EPS came in at -$0.03, compared to -$0.03 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.5 billion, representing a surprise of -4.74%. The company delivered an EPS surprise of -50.00%, with the consensus EPS estimate being -$0.02.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how RXO performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Eliminations: -$49 million versus the six-analyst average estimate of -$35.08 million.
  • Revenue- Truck brokerage: $1.07 billion versus the six-analyst average estimate of $1.17 billion.
  • Revenue- Complementary services: $415 million versus $391.86 million estimated by six analysts on average.
  • Revenue- Managed transportation: $137 million versus the six-analyst average estimate of $134.98 million.
  • Revenue- Last mile: $278 million versus $246.33 million estimated by six analysts on average.
  • Gross margin- Complementary services: $87 million compared to the $83.43 million average estimate based on two analysts.
  • Gross margin- Truck brokerage: $142 million versus the two-analyst average estimate of $145.10 million.
View all Key Company Metrics for RXO here>>>

Shares of RXO have returned +6.3% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


RXO INC (RXO) - free report >>

Published in